Kumaha Terapi Sasaran Ngarevolusikeun Pangobatan Kanker Lanjut?

  Targeted Therapy in Advanced Cancer: A Precision Approach to Treatment Targeted therapy has significantly transformed the therapeutic options for advanced cancer in the field of oncology. Targeted therapy differs from con..

Survivorship sareng perawatan jangka panjang dina kanker maju

    Understanding Survivorship in the Context of Advanced Cancers Survivorship, once a term associated predominantly with those in remission, has evolved. Today, it encompasses a multifaceted journey that includes i..

Statistik kanker di India 2024: Kajadian, perkiraan sareng ramalan

Cancer incidence, statistics, and estimates 2024: Results from National Cancer Registry Program Cancer incidence rates are increasing at an alarming rate in India, and are anticipated to grow by 12% over the next five years. As a..

India

India nyatakeun ibukota kanker dunya - laporan Apollo

India nyatakeun ibukota kanker dunya India ditunjuk salaku "ibukota kanker dunya" dina édisi ka-4 Apollo Hospitals 'Health of the Nation Report, anu diterbitkeun dina Poé Kaséhatan Dunia 2024. Nurutkeun ..

Pangobatan Anu Ngarobah Kahirupan pikeun Kanker Darah Tungtungna Kakeunaan!

Blood cancer is a type of cancer that affects both the blood and bone marrow. It is the fifth most common type of cancer in the world, with around 1.24 million new cases diagnosed each year. Wondering is blood cancer curable? Fin..

Uji klinis Terapi T-Cell CAR Di Cina Némbongkeun Kasuksésan Anu Luar Biasa

2024 has been a game-changer for CAR T-Cell therapy in China! Witness remarkable success stories from clinical trials, explore advancements, and learn about the remaining challenges. Come discover the future of this ground-breaki..

Tinjauan Langkung Deukeut Dina Uji Klinis Kanker Anyar Di Cina Sareng Narkoba Kanker Anyar Disatujuan

This article closely examines cancer clinical trials in China in the past few years, focusing on major findings and areas of progress. It also discusses newly approved cancer drugs in China, examining their mechanism of action, e..

NMPA Approves FUCASO: Multiple Myeloma Treatment Di Cina

The overall response rate of this revolutionary cancer therapy named FUCASO is 96%. The NMPA's approval marks a turning point in China's fight against multiple myeloma. This blog explores the effectiveness of this therapy, its s..

The Inside Scoop on Biaya Perawatan Kanker Payudara di India - Wahyu Anu Kedah Dibaca!

Kanker payudara nyababkeun 31% tina sadaya kanker anu didiagnosis di awéwé India, sahingga janten jinis kanker utama. Panyakit serius ieu kedah diubaran dina tahap awal pikeun hasil anu pangsaéna. Blog urang ngarecah kanker payudara t..

Kumaha scanning PET CT ngarobih kahirupan pasien kanker di dunya?

A PET scan is a ray of hope in the fight against cancer. If your doctor suspects a case of cancer, they might use this imaging method for an accurate diagnosis. Read our informative guide to learn all about this revolutionary tec..